Reelin has a preventive effect on phencyclidine-induced cognitive and sensory-motor gating deficits

Neuroscience Research

Volumn 96, Issue , 2015, Pages 30-36

  Ishii, Kazuhiro ^a   Nagai, Taku ^b   Hirota, Yuki ^a   Noda, Mariko ^a   Nabeshima, Toshitaka ^c,d   Yamada, Kiyofumi ^b   Kubo, Ken ichiro ^a   Nakajima, Kazunori ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c MEIJO UNIVERSITY   (Japan)

^d Japanese Drug Organization of Appropriate Use and Research   (Japan)

Author keywords

Cognitive deficits; GABAergic interneuron; Phencyclidine; Reelin; Schizophrenia; Sonsory motor gating deficits

Indexed keywords

PHENCYCLIDINE; RECEPTOR PROTEIN; REELIN; REELIN RECEPTOR; UNCLASSIFIED DRUG; 4 AMINOBUTYRIC ACID RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR; NERVE CELL ADHESION MOLECULE; NERVE PROTEIN; REELIN PROTEIN; SCLEROPROTEIN; SERINE PROTEINASE; VERY LOW DENSITY LIPOPROTEIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; COGNITIVE DEFECT; CONTROLLED STUDY; LATERAL BRAIN VENTRICLE; MALE; MEDIAL PREFRONTAL CORTEX; MENTAL DISEASE; MOTIVATION; MOUSE; NERVE CELL; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; PHENOTYPE; PREPULSE INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHIZOPHRENIA; SENSORY MOTOR GATING DEFICIT; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; COGNITION DISORDERS; DRUG EFFECTS; INSTITUTE FOR CANCER RESEARCH MOUSE; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; METABOLISM; PREFRONTAL CORTEX; SENSORY GATING;

ANIMALS; CELL ADHESION MOLECULES, NEURONAL; COGNITION DISORDERS; EXTRACELLULAR MATRIX PROTEINS; GABAERGIC NEURONS; INFUSIONS, INTRAVENTRICULAR; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED ICR; NERVE TISSUE PROTEINS; NEURONS; PHENCYCLIDINE; PREFRONTAL CORTEX; RECEPTORS, LDL; SENSORY GATING; SERINE ENDOPEPTIDASES;

EID: 84929951165     PISSN: 01680102     EISSN: 18728111     Source Type: Journal    
DOI: 10.1016/j.neures.2014.12.013     Document Type: Article

References (60)

1. Arguello P.A., Gogos J.A. Modeling madness in mice: one piece at a time. Neuron 2006, 52:179-196.
2. Bar I., Lambert De Rouvroit C., Royaux I., Krizman D.B., Dernoncourt C., Ruelle D., Beckers M.C., Goffinet A.M. A YAC contig containing the reeler locus with preliminary characterization of candidate gene fragments. Genomics 1995, 26:543-549.
3. Barr A.M., Fish K.N., Markou A. The reelin receptors VLDLR and ApoER2 regulate sensorimotor gating in mice. Neuropharmacology 2007, 52:1114-1123.
4. Beffert U., Weeber E.J., Durudas A., Qiu S., Masiulis I., Sweatt J.D., Li W.P., Adelmann G., Frotscher M., Hammer R.E., Herz J. Modulation of synaptic plasticity and memory by Reelin involves differential splicing of the lipoprotein receptor Apoer2. Neuron 2005, 47:567-579.
5. Botella-Lopez A., Burgaya F., Gavin R., Garcia-Ayllon M.S., Gomez-Tortosa E., Pena-Casanova J., Urena J.M., Del Rio J.A., Blesa R., Soriano E., Saez-Valero J. Reelin expression and glycosylation patterns are altered in Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:5573-5578.
6. Bothwell M., Giniger E. Alzheimer's disease: neurodevelopment converges with neurodegeneration. Cell 2000, 102:271-273.
7. Breier A., Malhotra A.K., Pinals D.A., Weisenfeld N.I., Pickar D. Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers. Am. J. Psychiatry 1997, 154:805-811.
8. Campo C.G., Sinagra M., Verrier D., Manzoni O.J., Chavis P. Reelin secreted by GABAergic neurons regulates glutamate receptor homeostasis. PLoS ONE 2009, 4:e5505.
9. Chen Y., Beffert U., Ertunc M., Tang T.S., Kavalali E.T., Bezprozvanny I., Herz J. Reelin modulates NMDA receptor activity in cortical neurons. J. Neurosci. 2005, 25:8209-8216.
10. D'Arcangelo G., Miao G.G., Chen S.C., Soares H.D., Morgan J.I., Curran T. A protein related to extracellular matrix proteins deleted in the mouse mutant reeler. Nature 1995, 374:719-723.
11. D'Arcangelo G., Nakajima K., Miyata T., Ogawa M., Mikoshiba K., Curran T. Reelin is a secreted glycoprotein recognized by the CR-50 monoclonal antibody. J. Neurosci. 1997, 17:23-31.
12. de Bergeyck V., Naerhuyzen B., Goffinet A.M., Lambert de Rouvroit C. A panel of monoclonal antibodies against reelin, the extracellular matrix protein defective in reeler mutant mice. J. Neurosci. Methods 1998, 82:17-24.
13. de Bergeyck V., Nakajima K., Lambert de Rouvroit C., Naerhuyzen B., Goffinet A.M., Miyata T., Ogawa M., Mikoshiba K. A truncated Reelin protein is produced but not secreted in the 'Orleans' reeler mutation (Reln[rl-Orl]). Brain Res. Mol. Brain Res. 1997, 50:85-90.
14. Fatemi S.H., Earle J.A., McMenomy T. Reduction in Reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression. Mol. Psychiatry 2000, 5:654-663. 571.
15. Fatemi S.H., Stary J.M., Egan E.A. Reduced blood levels of reelin as a vulnerability factor in pathophysiology of autistic disorder. Cell. Mol. Neurobiol. 2002, 22:139-152.
16. Goes F.S., Willour V.L., Zandi P.P., Belmonte P.L., MacKinnon D.F., Mondimore F.M., Schweizer B., DePaulo J.R., Gershon E.S., McMahon F.J., Potash J.B. Sex-specific association of the Reelin gene with bipolar disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2010, 153B:549-553.
17. Gonzalez-Burgos G., Lewis D.A. NMDA receptor hypofunction, parvalbumin-positive neurons, and cortical gamma oscillations in schizophrenia. Schizophr. Bull. 2012, 38:950-957.
18. Guidotti A., Auta J., Davis J.M., Di-Giorgi-Gerevini V., Dwivedi Y., Grayson D.R., Impagnatiello F., Pandey G., Pesold C., Sharma R., Uzunov D., Costa E. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch. Gen. Psychiatry 2000, 57:1061-1069.
19. Hajszan T., Leranth C., Roth R.H. Subchronic phencyclidine treatment decreases the number of dendritic spine synapses in the rat prefrontal cortex. Biol. Psychiatry 2006, 60:639-644.
20. Herz J., Chen Y. Reelin, lipoprotein receptors and synaptic plasticity. Nat. Rev. Neurosci. 2006, 7:850-859.
21. Hirota Y., Kubo K.I., Katayama K.I., Honda T., Fujino T., Yamamoto T.T., Nakajima K. Reelin receptors ApoER2 and VLDLR are expressed in distinct spatio-temporal patterns in developing mouse cerebral cortex. J. Comp. Neurol. 2014, 523:463-478.
22. Homayoun H., Moghaddam B. NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons. J. Neurosci. 2007, 27:11496-11500.
23. Impagnatiello F., Guidotti A.R., Pesold C., Dwivedi Y., Caruncho H., Pisu M.G., Uzunov D.P., Smalheiser N.R., Davis J.M., Pandey G.N., Pappas G.D., Tueting P., Sharma R.P., Costa E. A decrease of reelin expression as a putative vulnerability factor in schizophrenia. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:15718-15723.
24. Jackson M.E., Homayoun H., Moghaddam B. NMDA receptor hypofunction produces concomitant firing rate potentiation and burst activity reduction in the prefrontal cortex. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:8467-8472.
25. Javitt D.C. Glutamate as a therapeutic target in psychiatric disorders. Mol. Psychiatry 2004, 9:984-997. 979.
26. Javitt D.C., Zukin S.R. Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry 1991, 148:1301-1308.
27. Jodo E., Suzuki Y., Katayama T., Hoshino K.Y., Takeuchi S., Niwa S., Kayama Y. Activation of medial prefrontal cortex by phencyclidine is mediated via a hippocampo-prefrontal pathway. Cereb. Cortex 2005, 15:663-669.
28. Kargieman L., Santana N., Mengod G., Celada P., Artigas F. Antipsychotic drugs reverse the disruption in prefrontal cortex function produced by NMDA receptor blockade with phencyclidine. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:14843-14848.
29. Kiss T., Hoffmann W.E., Scott L., Kawabe T.T., Milici A.J., Nilsen E.A., Hajos M. Role of thalamic projection in NMDA receptor-induced disruption of cortical slow oscillation and short-term plasticity. Front. Psychiatry 2011, 2:14.
30. Knuesel I. Reelin-mediated signaling in neuropsychiatric and neurodegenerative diseases. Prog. Neurobiol. 2010, 91:257-274.
31. Koie M., Okumura K., Hisanaga A., Kamei T., Sasaki K., Deng M., Baba A., Kohno T., Hattori M. Cleavage within Reelin repeat 3 regulates the duration and range of the signaling activity of Reelin protein. J. Biol. Chem. 2014, 289:12922-12930.
32. Kramer P.L., Xu H., Woltjer R.L., Westaway S.K., Clark D., Erten-Lyons D., Kaye J.A., Welsh-Bohmer K.A., Troncoso J.C., Markesbery W.R., Petersen R.C., Turner R.S., Kukull W.A., Bennett D.A., Galasko D., Morris J.C., Ott J. Alzheimer disease pathology in cognitively healthy elderly: a genome-wide study. Neurobiol. Aging 2011, 32:2113-2122.
33. Kubo K., Honda T., Tomita K., Sekine K., Ishii K., Uto A., Kobayashi K., Tabata H., Nakajima K. Ectopic Reelin induces neuronal aggregation with a normal birthdate-dependent inside-out alignment in the developing neocortex. J. Neurosci. 2010, 30:10953-10966.
34. Kubo K., Mikoshiba K., Nakajima K. Secreted Reelin molecules form homodimers. Neurosci. Res. 2002, 43:381-388.
35. Lahti A.C., Holcomb H.H., Medoff D.R., Tamminga C.A. Ketamine activates psychosis and alters limbic blood flow in schizophrenia. Neuroreport 1995, 6:869-872.
36. Liu Y., Chen P.L., McGrath J., Wolyniec P., Fallin D., Nestadt G., Liang K.Y., Pulver A., Valle D., Avramopoulos D. Replication of an association of a common variant in the Reelin gene (RELN) with schizophrenia in Ashkenazi Jewish women. Psychiatr. Genet. 2010, 20:184-186.
37. Marin O. Interneuron dysfunction in psychiatric disorders. Nat. Rev. Neurosci. 2012, 13:107-120.
38. Mouri A., Noda Y., Enomoto T., Nabeshima T. Phencyclidine animal models of schizophrenia: approaches from abnormality of glutamatergic neurotransmission and neurodevelopment. Neurochem. Int. 2007, 51:173-184.
39. Nagai T., Takuma K., Dohniwa M., Ibi D., Mizoguchi H., Kamei H., Nabeshima T., Yamada K. Repeated methamphetamine treatment impairs spatial working memory in rats: reversal by clozapine but not haloperidol. Psychopharmacology (Berl) 2007, 194:21-32.
40. Nakazawa K., Zsiros V., Jiang Z., Nakao K., Kolata S., Zhang S., Belforte J.E. GABAergic interneuron origin of schizophrenia pathophysiology. Neuropharmacology 2012, 62:1574-1583.
41. Niu S., Renfro A., Quattrocchi C.C., Sheldon M., D'Arcangelo G. Reelin promotes hippocampal dendrite development through the VLDLR/ApoER2-Dab1 pathway. Neuron 2004, 41:71-84.
42. Niu S., Yabut O., D'Arcangelo G. The Reelin signaling pathway promotes dendritic spine development in hippocampal neurons. J. Neurosci. 2008, 28:10339-10348.
43. Niwa H., Yamamura K., Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 1991, 108:193-199.
44. Ogawa M., Miyata T., Nakajima K., Yagyu K., Seike M., Ikenaka K., Yamamoto H., Mikoshiba K. The reeler gene-associated antigen on Cajal-Retzius neurons is a crucial molecule for laminar organization of cortical neurons. Neuron 1995, 14:899-912.
45. Olson E.C., Kim S., Walsh C.A. Impaired neuronal positioning and dendritogenesis in the neocortex after cell-autonomous Dab1 suppression. J. Neurosci. 2006, 26:1767-1775.
46. Pujadas L., Gruart A., Bosch C., Delgado L., Teixeira C.M., Rossi D., de Lecea L., Martinez A., Delgado-Garcia J.M., Soriano E. Reelin regulates postnatal neurogenesis and enhances spine hypertrophy and long-term potentiation. J. Neurosci. 2010, 30:4636-4649.
47. Qiu S., Weeber E.J. Reelin signaling facilitates maturation of CA1 glutamatergic synapses. J. Neurophysiol. 2007, 97:2312-2321.
48. Qiu S., Zhao L.F., Korwek K.M., Weeber E.J. Differential reelin-induced enhancement of NMDA and AMPA receptor activity in the adult hippocampus. J. Neurosci. 2006, 26:12943-12955.
49. Rogers J.T., Rusiana I., Trotter J., Zhao L., Donaldson E., Pak D.T., Babus L.W., Peters M., Banko J.L., Chavis P., Rebeck G.W., Hoe H.S., Weeber E.J. Reelin supplementation enhances cognitive ability, synaptic plasticity, and dendritic spine density. Learn. Mem. 2011, 18:558-564.
50. Shifman S., Johannesson M., Bronstein M., Chen S.X., Collier D.A., Craddock N.J., Kendler K.S., Li T., O'Donovan M., O'Neill F.A., Owen M.J., Walsh D., Weinberger D.R., Sun C., Flint J., Darvasi A. Genome-wide association identifies a common variant in the reelin gene that increases the risk of schizophrenia only in women. PLoS Genet. 2008, 4:e28.
51. Sinagra M., Verrier D., Frankova D., Korwek K.M., Blahos J., Weeber E.J., Manzoni O.J., Chavis P. Reelin, very-low-density lipoprotein receptor, and apolipoprotein E receptor 2 control somatic NMDA receptor composition during hippocampal maturation in vitro. J. Neurosci. 2005, 25:6127-6136.
52. Skaar D.A., Shao Y., Haines J.L., Stenger J.E., Jaworski J., Martin E.R., DeLong G.R., Moore J.H., McCauley J.L., Sutcliffe J.S., Ashley-Koch A.E., Cuccaro M.L., Folstein S.E., Gilbert J.R., Pericak-Vance M.A. Analysis of the RELN gene as a genetic risk factor for autism. Mol. Psychiatry 2005, 10:563-571.
53. Snyder M.A., Gao W.J. NMDA hypofunction as a convergence point for progression and symptoms of schizophrenia. Front. Cell. Neurosci. 2013, 7:31.
54. Southwell D.G., Froemke R.C., Alvarez-Buylla A., Stryker M.P., Gandhi S.P. Cortical plasticity induced by inhibitory neuron transplantation. Science 2010, 327:1145-1148.
55. Tabata H., Nakajima K. Multipolar migration: the third mode of radial neuronal migration in the developing cerebral cortex. J. Neurosci. 2003, 23:9996-10001.
56. Takahashi K., Nagai T., Kamei H., Maeda K., Matsuya T., Arai S., Mizoguchi H., Yoneda Y., Nabeshima T., Takuma K., Yamada K. Neural circuits containing pallidotegmental GABAergic neurons are involved in the prepulse inhibition of the startle reflex in mice. Biol. Psychiatry 2007, 62:148-157.
57. Tanaka D.H., Toriumi K., Kubo K., Nabeshima T., Nakajima K. GABAergic precursor transplantation into the prefrontal cortex prevents phencyclidine-induced cognitive deficits. J. Neurosci. 2011, 31:14116-14125.
58. Teixeira C.M., Martin E.D., Sahun I., Masachs N., Pujadas L., Corvelo A., Bosch C., Rossi D., Martinez A., Maldonado R., Dierssen M., Soriano E. Overexpression of Reelin prevents the manifestation of behavioral phenotypes related to schizophrenia and bipolar disorder. Neuropsychopharmacology 2011, 36:2395-2405.
59. Utsunomiya-Tate N., Kubo K., Tate S., Kainosho M., Katayama E., Nakajima K., Mikoshiba K. Reelin molecules assemble together to form a large protein complex, which is inhibited by the function-blocking CR-50 antibody. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:9729-9734.
60. Weeber E.J., Beffert U., Jones C., Christian J.M., Forster E., Sweatt J.D., Herz J. Reelin and ApoE receptors cooperate to enhance hippocampal synaptic plasticity and learning. J. Biol. Chem. 2002, 277:39944-39952.